​
​

Flora Growth (FLGC) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

FLGC Stock Forecast

Flora Growth stock forecast is as follows: an average price target of $173.50 (represents a 13144.27% upside from FLGC’s last price of $1.31) and a rating consensus of 'Hold', based on 2 wall street analysts offering a 1-year stock forecast.

FLGC Price Target

The average price target for Flora Growth (FLGC) is $173.50 based on 1-year price targets from 2 Wall Street analysts in the past 3 months, with a price target range of $340.00 to $7.00. This represents a potential 13144.27% upside from FLGC's last price of $1.31.

FLGC Analyst Ratings

Hold

According to 2 Wall Street analysts, Flora Growth's rating consensus is 'Hold'. The analyst rating breakdown for FLGC stock is 0 'Strong Buy' (0.00%), 0 'Buy' (0.00%), 2 'Hold' (100.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Flora Growth Price Target by Analyst

DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 03, 2024William KirkRoth Capital--241.46%434.35%
Aug 08, 2022Pablo ZuanicCantor Fitzgerald--11.77%25854.20%
Row per page
Go to

The latest Flora Growth stock forecast, released on Apr 03, 2024 by William Kirk from Roth Capital, set a price target of $7.00, which represents a 241.46% increase from the stock price at the time of the forecast ($2.05), and a 434.35% increase from FLGC last price ($1.31).

Flora Growth Price Target by Period

1M3M12M
# Anlaysts--1
Avg Price Target--$7.00
Last Closing Price$1.31$1.31$1.31
Upside/Downside-100.00%-100.00%434.35%

In the current month, the average price target of Flora Growth stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Flora Growth's last price of $1.31. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

DateCompanyPrevious RatingNew RatingRating Change
Aug 15, 2024Alliance Global PartnersBuyNeutralDowngrade
Apr 05, 2024Alliance Global PartnersBuyBuyHold
Aug 08, 2022Cantor FitzgeraldNeutralInitialise
Row per page
Go to

Flora Growth's last stock rating was published by Alliance Global Partners on Aug 15, 2024. The company Downgrade its FLGC rating from "Buy" to "Neutral".

Flora Growth Financial Forecast

Flora Growth Revenue Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22
Revenue---------$17.32M$21.46M$20.11M$11.49M$10.77M$4.95M
Avg Forecast$18.20M$17.15M$17.01M$17.14M$15.57M$16.77M$20.74M$19.04M$16.52M$21.10M$20.80M$22.96M$12.97M$11.35M$1.40M
High Forecast$19.39M$18.28M$18.12M$18.20M$17.60M$17.87M$20.74M$19.04M$17.60M$22.49M$22.17M$24.46M$13.82M$11.35M$1.40M
Low Forecast$17.00M$16.02M$15.89M$16.07M$13.53M$15.67M$20.74M$19.04M$15.43M$19.71M$19.43M$21.45M$12.12M$11.35M$1.40M
# Analysts111211111111111
Surprise %---------0.82%1.03%0.88%0.89%0.95%3.53%

Flora Growth's average Quarter revenue forecast for Dec 23 based on 1 analysts is $16.52M, with a low forecast of $15.43M, and a high forecast of $17.60M. FLGC's average Quarter revenue forecast represents a -4.62% decrease compared to the company's last Quarter revenue of $17.32M (Sep 23).

Flora Growth EBITDA Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22
# Analysts111211111111111
EBITDA---------$-248.00K$-4.16M$-2.11M$22.31M$-3.39M$-7.22M
Avg Forecast$-7.59M$-7.15M$-7.09M$-7.15M$-6.49M$-6.99M$-8.65M$-7.94M$-6.89M$-8.80M$-8.67M$-9.57M$-5.41M$-2.10M$-258.61K
High Forecast$-7.09M$-6.68M$-6.63M$-6.70M$-5.64M$-6.53M$-8.65M$-7.94M$-6.43M$-8.22M$-8.10M$-8.94M$-5.05M$-2.10M$-258.61K
Low Forecast$-8.09M$-7.62M$-7.56M$-7.59M$-7.34M$-7.45M$-8.65M$-7.94M$-7.34M$-9.38M$-9.24M$-10.20M$-5.76M$-2.10M$-258.61K
Surprise %---------0.03%0.48%0.22%-4.12%1.62%27.91%

1 analysts predict FLGC's average Quarter EBITDA for Mar 23 to be $-9.57M, with a high of $-8.94M and a low of $-10.20M. This is -142.90% lower than Flora Growth's previous annual EBITDA (Dec 22) of $22.31M.

Flora Growth Net Income Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22
# Analysts111211111111111
Net Income---------$1.24M$-44.56M$-3.90M$-12.53M$-7.36M$-7.53M
Avg Forecast$472.70K$252.37K$20.70K$-88.80K$-1.08M$-1.17M$-590.20K$-2.91M$-933.37K$-2.67M$-5.34M$-9.35M$-17.80M$-14.73M$-3.68M
High Forecast$513.06K$273.92K$22.46K$266.39K$-674.74K$-1.07M$-539.80K$-2.66M$-466.69K$-2.44M$-4.89M$-8.55M$-16.28M$-14.73M$-3.68M
Low Forecast$432.33K$230.82K$18.93K$-355.19K$-1.48M$-1.27M$-640.60K$-3.15M$-1.33M$-2.90M$-5.80M$-10.15M$-19.32M$-14.73M$-3.68M
Surprise %----------0.46%8.34%0.42%0.70%0.50%2.04%

Flora Growth's average Quarter net income forecast for Dec 23 is $-933.37K, with a range of $-1.33M to $-466.69K. FLGC's average Quarter net income forecast represents a -175.45% decrease compared to the company's last Quarter net income of $1.24M (Sep 23).

Flora Growth SG&A Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22
# Analysts111211111111111
SG&A---------$4.53M$6.92M$6.93M$8.38M$7.56M$8.90M
Avg Forecast$421.82M$397.60M$394.24M$397.25M$360.86M$388.68M$480.78M$441.37M$382.89M$489.13M$482.18M$532.18M$300.70M$262.79M$32.41M
High Forecast$449.53M$423.72M$420.13M$421.86M$408.08M$414.20M$480.78M$441.37M$408.04M$521.26M$513.85M$567.14M$320.46M$262.79M$32.41M
Low Forecast$394.12M$371.48M$368.34M$372.64M$313.64M$363.15M$480.77M$441.36M$357.74M$457.00M$450.51M$497.23M$280.95M$262.79M$32.41M
Surprise %---------0.01%0.01%0.01%0.03%0.03%0.27%

Flora Growth's average Quarter SG&A projection for Dec 23 is $382.89M, based on 1 Wall Street analysts, with a range of $357.74M to $408.04M. The forecast indicates a 8346.75% rise compared to FLGC last annual SG&A of $4.53M (Sep 23).

Flora Growth EPS Forecast

Dec 25Sep 25Jun 25Mar 25Dec 24Sep 24Jun 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Mar 22
# Analysts111211111111111
EPS---------$0.18$-6.62$-0.03$-0.30$-0.10$-0.11
Avg Forecast$0.04$0.02-$-0.01$-0.08$-0.09$-0.04$-0.22$-0.07$-0.20$-0.40$-0.70$-1.33$-1.20$-0.30
High Forecast$0.04$0.02-$0.02$-0.05$-0.08$-0.04$-0.20$-0.03$-0.18$-0.37$-0.64$-1.22$-1.20$-0.30
Low Forecast$0.03$0.02-$-0.03$-0.11$-0.10$-0.05$-0.24$-0.10$-0.22$-0.43$-0.76$-1.45$-1.20$-0.30
Surprise %----------0.90%16.55%0.04%0.23%0.08%0.37%

According to 1 Wall Street analysts, Flora Growth's projected average Quarter EPS for Dec 23 is $-0.07, with a low estimate of $-0.10 and a high estimate of $-0.03. This represents a -138.83% decrease compared to FLGC previous annual EPS of $0.18 (Sep 23).

Flora Growth Peer Comparison by Price Target

TickerCompanyLast Closing PriceAvg Price TargetUpside/DownsideAvg Rating
FLGCFlora Growth--13144.27%Hold
CLVRClever Leaves---Buy
GHSIGuardion Health Sciences---99.69%Buy

FLGC Forecast FAQ

Is Flora Growth a good buy?

No, according to 2 Wall Street analysts, Flora Growth (FLGC) is considered a 'Hold'. The rating consensus is based on 0 'Strong Buy' and 0 'Buy' recommendations, accounting for 0% of FLGC's total ratings.

What is FLGC's price target?

Flora Growth (FLGC) average price target is $173.5 with a range of $7 to $340, implying a 13144.27% from its last price of $1.31. The data is based on 2 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Flora Growth stock go up soon?

According to Wall Street analysts' prediction for FLGC stock, the company can go up by 13144.27% (from the last price of $1.31 to the average price target of $173.5), up by 25854.20% based on the highest stock price target, and up by 434.35% based on the lowest stock price target.

Can Flora Growth stock reach $2?

FLGC's average twelve months analyst stock price target of $173.5 supports the claim that Flora Growth can reach $2 in the near future.

What are Flora Growth's analysts' financial forecasts?

Flora Growth's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $72.11M (high $75.25M, low $68.97M), average EBITDA is $-30.068M (high $-28.76M, low $-31.377M), average net income is $-5.748M (high $-4.945M, low $-6.552M), average SG&A $1.67B (high $1.74B, low $1.6B), and average EPS is $-0.43 (high $-0.37, low $-0.491). FLGC's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $69.49M (high $73.99M, low $64.99M), average EBITDA is $-28.976M (high $-27.099M, low $-30.852M), average net income is $656.97K (high $1.08M, low $326.89K), average SG&A $1.61B (high $1.72B, low $1.51B), and average EPS is $0.0492 (high $0.0806, low $0.0245).

Did the FLGC's actual financial results beat the analysts' financial forecasts?

Based on Flora Growth's last annual report (Dec 2023), the company's revenue was $76.07M, which missed the average analysts forecast of $81.37M by -6.52%. Apple's EBITDA was $-45.87M, beating the average prediction of $-33.93M by 35.19%. The company's net income was $-57.036M, beating the average estimation of $-18.292M by 211.80%. Apple's SG&A was $3.95M, missing the average forecast of $1.89B by -99.79%. Lastly, the company's EPS was $-7.75, beating the average prediction of $-1.37 by 465.73%. In terms of the last quarterly report (Sep 2023), Flora Growth's revenue was $17.32M, missing the average analysts' forecast of $21.1M by -17.93%. The company's EBITDA was $-248K, missing the average prediction of $-8.798M by -97.18%. Flora Growth's net income was $1.24M, missing the average estimation of $-2.671M by -146.32%. The company's SG&A was $4.53M, missing the average forecast of $489.13M by -99.07%. Lastly, the company's EPS was $0.18, missing the average prediction of $-0.2 by -190.00%